Taking time out for regular exercise and sticking to a balanced diet are keys to losing weight. So how does a chef who works long hours around food hope to shed extra kilos? Ngo Xing Jun ...

A new study from the University of Illinois Urbana-Champaign suggests that incorporating small portions of craved foods into a balanced diet can actually aid in weight loss and reduce cravings.

sought to measure weight gain after stopping the use of weight loss medication, or GLP-1 receptor agonists. Researchers determined that ceasing older weight loss medications resulted in a return ...

TV chef, 74, shares secret to three stone weight loss and 'creating a second chance at life' - The This Morning star weighed ...

Share on Pinterest Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly. Shelby Knowles/Bloomberg/Getty Images Zepbound outperformed ...

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer. By Rebecca Robbins Novo Nordisk will replace its ...

Share on Pinterest New research explores the potential of protein bars enriched with collagen as a weight loss aid. Jeff Wasserman/Stocksy A study conducted by Spanish researchers analyzed how ...

After fans took notice of her new appearance, Trainor addressed her significant weight loss on Instagram, attributing her transformation to "huge lifestyle changes" such as using the weight-loss ...

Weight-loss medications known as glucagon-like peptide-1 (GLP-1) agonists, which have gained popularity for treating type 2 diabetes and obesity, have been shown to have the surprising secondary ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Shweta Tiwari's post-pregnancy weight loss journey inspires many, as she shed over 10 kilos in her 40s through mindful changes. Shweta Tiwari didn’t just lose weight. She gained more energy ...

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published, examining their ability to reduce weight and waist circumference.